Patent · US Active

Method of isolating anti-viral ingredients from Baphicacanthus cusia, compositions comprising them and their medical use

US10537601B2 · kind B2 · utility

0Cited by
0References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 4, 2016
Grant dateJan 21, 2020
Priority date
Expiry dateSep 28, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2236/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a method of isolating at least one ingredient with anti-viral efficacy from Baphicacanthus cusia. The ingredient can be an alkaloid, a triterpenoid, a lignan, a phenylethanoid, a sesquiterpene lactone, or a flavonoid. Two new alkaloids are produced, which have not been previously reported. Moreover, the method isolates 12 compounds which could not or have not been previously isolated. A pharmaceutical composition includes the at least one ingredient and at least one pharmaceutical tolerable excipient. A method of treating a subject suffering from a viral disease includes administering at least one ingredient isolated from Baphicacanthus cusia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.